Aerin Medical Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
154
- Latest Deal Type
-
Series G
- Latest Deal Amount
-
$55.1M
- Investors
-
16
Aerin Medical General Information
Description
Manufacturer of non-invasive medical devices intended to provide relief for chronic nasal conditions. The company offers a compact touch-screen console that utilizes temperature-controlled radiofrequency technology to deliver precise treatments for nasal airway obstruction and chronic rhinitis, enabling physicians to effectively manage these conditions for patients seeking lasting relief.
Contact Information
Website
www.aerinmedical.comCorporate Office
- 232 East Caribbean Drive
- Sunnyvale, CA 94089
- United States
Corporate Office
- 232 East Caribbean Drive
- Sunnyvale, CA 94089
- United States
Aerin Medical Timeline
Aerin Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series G) | 27-Dec-2024 | $55.1M | Completed | Generating Revenue | ||
| 9. Later Stage VC (Series F) | 16-Jun-2022 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series E) | 17-Aug-2020 | Completed | Generating Revenue | |||
| 7. Debt Refinancing | 23-May-2019 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 19-Dec-2017 | Completed | Generating Revenue | |||
| 5. Mezzanine | 13-Dec-2017 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 21-Mar-2016 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 13-Feb-2014 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 12-Oct-2012 | $125K | $250K | Completed | Startup | |
| 1. Early Stage VC (Series A) | 12-Dec-2011 | $125K | $125K | Completed | Startup |
Aerin Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series G | ||||||||
| Series F | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 646,763 | $0.001000 | $0.06 | $0.77 | $0.77 | 1x | $0.77 | 0.22% |
| Series A | 1,010,560 | $0.001000 | $0.05 | $0.57 | $0.57 | 1x | $0.57 | 0.34% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Aerin Medical Comparisons
Industry
Financing
Details
Aerin Medical Competitors (3)
One of Aerin Medical’s 3 competitors is Neurent Medical, a Venture Capital-Backed company based in Galway, Ireland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neurent Medical | Venture Capital-Backed | Galway, Ireland | ||||
| Nasal Medical | Venture Capital-Backed | Dunboyne, Ireland | ||||
| MaxAir Nose Cones | Formerly Accelerator/Incubator backed | Beverly, MA |
Aerin Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aerin Medical Patents
Aerin Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1082790-S1 | Stylus | Active | 14-Feb-2024 | ||
| US-20240423704-A1 | Ethmoidal nerve treatment system and method | Pending | 26-Jun-2023 | ||
| US-20220313985-A1 | Nasal neuromodulation devices and methods | Pending | 06-Apr-2021 | ||
| US-20220151689-A1 | Soft palate treatment | Pending | 16-Nov-2020 | ||
| EP-3909551-A2 | Soft palate treatment | Inactive | 13-May-2020 | A61F5/56 |
Aerin Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aerin Medical Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ares Management | Asset Manager | Minority | ||
| CION Investments | Lender/Debt Provider | Minority | ||
| Ally Bridge Group | PE/Buyout | Minority | ||
| CRG | Lender/Debt Provider | Minority | ||
| KCK MedTech | Venture Capital | Minority |
Aerin Medical FAQs
-
When was Aerin Medical founded?
Aerin Medical was founded in 2011.
-
Where is Aerin Medical headquartered?
Aerin Medical is headquartered in Sunnyvale, CA.
-
What is the size of Aerin Medical?
Aerin Medical has 154 total employees.
-
What industry is Aerin Medical in?
Aerin Medical’s primary industry is Therapeutic Devices.
-
Is Aerin Medical a private or public company?
Aerin Medical is a Private company.
-
What is the current valuation of Aerin Medical?
The current valuation of Aerin Medical is .
-
What is Aerin Medical’s current revenue?
The current revenue for Aerin Medical is .
-
How much funding has Aerin Medical raised over time?
Aerin Medical has raised $258M.
-
Who are Aerin Medical’s investors?
Ares Management, CION Investments, Ally Bridge Group, CRG, and KCK MedTech are 5 of 16 investors who have invested in Aerin Medical.
-
Who are Aerin Medical’s competitors?
Neurent Medical, Nasal Medical, and MaxAir Nose Cones are competitors of Aerin Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
